Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

Immunological Memory

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...

Active versus Passive Immunity

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...

Development of Immunocompetence

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Age at First RSV Hospitalisation and the Risk of Subsequent Bacterial Pneumonia.

Acta paediatrica (Oslo, Norway : 1992)·2026

Same author

Burden of Hospitalized Respiratory Syncytial Virus in Children in Sweden: A Population-based Case-cohort Study (2006-2023).

The Pediatric infectious disease journal·2025

Same author

NorthPop: a prospective population-based birth cohort study.

BMC public health·2025

Same author

Respiratory morbidity before and during the COVID-19 pandemic from birth to 18 months in a Swedish birth cohort.

The Journal of allergy and clinical immunology·2024

Same author

Adult Work Ability Following Diagnosis of Bacterial Meningitis in Childhood.

JAMA network open·2024

Same author

Increased risk of bacterial pneumonia before and after respiratory syncytial virus infection in young children.

Acta paediatrica (Oslo, Norway : 1992)·2024

Same journal

Fas-Ligand Mediated Apoptosis in Severe Sepsis and Shock.

Scandinavian journal of infectious diseases·2017

Same journal

Lipopolysaccharide-inducible Gene Expression Profile in Human Monocytes.

Scandinavian journal of infectious diseases·2017

Same journal

Fatal varicella pneumonia.

Scandinavian journal of infectious diseases·2015

Same journal

Wissler's Syndrome Associated with Parainfluenza 2 Infection.

Scandinavian journal of infectious diseases·2015

Same journal

Contamination of smears with "sergentella spiroides".

Scandinavian journal of infectious diseases·2015

Same journal

Recrudescent typhus: fluctuations in titers of complement-fixing and microagglutinating antibodies to rickettsia prowazeki in persons with a history of epidemic typhus.

Scandinavian journal of infectious diseases·2015

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Vaccination immunology.

Lars A Hanson¹, Sven Arne Silfverdal

¹Department of Clinical Immunology, University of Gothenburg, Sweden.

Scandinavian Journal of Infectious Diseases

|December 17, 2008

Summary

This summary is machine-generated.

The second golden era of vaccines leverages genetic insights into the immune system for improved vaccine development. Future vaccines must address challenges like genetic variability and environmental factors for diseases such as tuberculosis, malaria, and HIV.

More Related Videos

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

Related Experiment Videos

Last Updated: Jun 21, 2026

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

Area of Science:

Immunology
Vaccinology
Genetics

Background:

The first era of vaccine development yielded significant successes but also limitations, including inadequate protection and adverse effects.
Crucially, effective vaccines against major global diseases like tuberculosis, malaria, and HIV remain elusive.
Current vaccine research faces challenges in addressing pathogen diversity and host variability.

Purpose of the Study:

To outline the potential and challenges of the "second golden era of vaccines."
To highlight the importance of understanding immune system genetics for future vaccine design.
To identify key factors influencing vaccine efficacy that require further investigation.

Main Methods:

Review of current knowledge in vaccinology and immunology.
Analysis of genetic factors influencing immune responses, including human leukocyte antigen (HLA), cytokine, and cell-surface receptor gene variability.
Consideration of extrinsic factors impacting vaccine effectiveness.

Main Results:

The second golden era of vaccines is characterized by advancements in understanding immune system genetics.
Genetic variability in HLA, cytokines, and cell-surface receptors presents both challenges and opportunities for vaccine development.
Factors such as birth weight, gestational age, breastfeeding, helminth infections, and climate significantly impact vaccine efficacy and must be considered.

Conclusions:

Harnessing genetic insights into the immune system is critical for developing next-generation vaccines.
Addressing the complexities of host genetics and environmental influences is essential for overcoming limitations in current vaccine technology.
Future vaccine research must adopt a holistic approach, integrating immunological, genetic, and environmental considerations to combat infectious diseases effectively.